Lars Rombo

Lars Rombo is a Researcher at the Center for Clinical Research in Sörmland (CKFD), which is affiliated with Uppsala University's Faculty of Medicine. His work focuses on clinical research in vaccinology and infectious diseases, with particular emphasis on vaccine efficacy, safety, and immunogenicity in various populations including older adults and those in developing countries.

His primary research interests include:

• Vaccinology and vaccine development
• Infectious diseases, particularly malaria and vaccine-preventable diseases
• Clinical trials methodology
• Immunology of vaccine responses
• Travel medicine and tropical diseases
• Special population vaccination (older adults, immunocompromised)

Rombo's research spans both developed and developing world contexts, with significant work conducted in Guinea-Bissau focusing on childhood diarrhea and malaria epidemiology. His recent publications demonstrate a strong focus on herpes zoster vaccines, tick-borne encephalitis vaccines, and respiratory syncytial virus vaccines, particularly examining long-term efficacy, immunogenicity, and optimal dosing schedules.

His scientific contributions include:

• Long-term follow-up studies of zoster vaccine efficacy
• Research on optimal vaccination schedules for older adults
• Studies on vaccine interactions when co-administered
• Investigations into malaria treatment and drug resistance
• Epidemiological studies of infectious diseases in resource-limited settings

Rombo frequently collaborates with international research networks and has contributed to multiple large-scale clinical trials. His work has significant implications for vaccine policy and clinical practice guidelines worldwide.